참고문헌
- Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22. https://doi.org/10.1056/NEJMra032426
- Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007;167:2469-75. https://doi.org/10.1001/archinte.167.22.2469
- Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004;1:276-83. https://doi.org/10.1016/j.hrthm.2004.04.021
- Kim SM, Kim DS, Kim DI, et al. Quinidine-induced QTc interval prolongation and gender differences in healthy Korean subjects. Korean Circ J 2007;37:559-66. https://doi.org/10.4070/kcj.2007.37.11.559
- Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982;65:886-94. https://doi.org/10.1161/01.CIR.65.5.886
- De Ponti F, Poluzzi E, Montanaro N, Ferguson J. QTc and psychotropic drugs. Lancet 2000;356:75-6.
- Hoffmann P, Warner B. Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends. J Pharmacol Toxicol Methods 2006;53:87-105. https://doi.org/10.1016/j.vascn.2005.07.003
- Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther 2002;303:688-94. https://doi.org/10.1124/jpet.102.038240
- Donger C, Denjoy I, Berthet M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997; 96:2778-81. https://doi.org/10.1161/01.CIR.96.9.2778
- Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol 2000;11: 691-6. https://doi.org/10.1111/j.1540-8167.2000.tb00033.x
- Paulussen AD, Gilissen RA, Armstrong M, et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med 2004;82:182-8. https://doi.org/10.1007/s00109-003-0522-z
- Sesti F, Abbott GW, Wei J, et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A 2000;97:10613-8. https://doi.org/10.1073/pnas.180223197
- Hyun DW, Han SW, Jo YK, et al. Moleculogenetic characteristics of the patient with long QT syndrome in Korean. Korean Circ J 2004;34: 813-9.
- Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002;105:1943-8. https://doi.org/10.1161/01.CIR.0000014448.19052.4C
- Albert CM, MacRae CA, Chasman DI, et al. Common variants in car-diac ion channel genes are associated with sudden cardiac death. Circ Arrhythm Electrophysiol 2010;3:222-9. https://doi.org/10.1161/CIRCEP.110.944934
- Gouas L, Nicaud V, Berthet M, et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet 2005;13:1213-22. https://doi.org/10.1038/sj.ejhg.5201489
- Gouas L, Nicaud V, Chaouch S, et al. Confirmation of associations be-tween ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet 2007;15:974-9. https://doi.org/10.1038/sj.ejhg.5201866
- Pietila E, Fodstad H, Niskasaari E, et al. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol 2002;40:511-4. https://doi.org/10.1016/S0735-1097(02)01979-4
- Bezzina CR, Verkerk AO, Busjahn A, et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 2003;59:27-36. https://doi.org/10.1016/S0008-6363(03)00342-0
- Crotti L, Lundquist AL, Insolia R, et al. KCNH2-K897T is a genetic mo-difier of latent congenital long-QT syndrome. Circulation 2005;112: 1251-8. https://doi.org/10.1161/CIRCULATIONAHA.105.549071
피인용 문헌
- Long QT Syndrome and Perioperative Torsades de Pointes: What the Anesthesiologist Should Know vol.36, pp.1, 2011, https://doi.org/10.1053/j.jvca.2020.12.011
- 2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system vol.355, pp.None, 2011, https://doi.org/10.1016/j.toxlet.2021.11.016